Pfizer and BioNTech roll out new data for their bivalent booster against newer Omicron variants
As Pfizer and BioNTech tout the effectiveness of their bivalent booster against Omicron variants such as BA.4 and BA.5, more Covid-19 variants have been creeping …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.